According to reports from NDTV Profit, Siemens India, Zydus Lifesciences, Manappuram Finance, Kalpataru Projects International, Astra Microwave Products, KEC International, Dilip Buildcon, Greenpanel Industries, Tata Motors CV, Tata Motors Passenger Vehicles, Apollo Hospitals, Max Financial Services, Petronet LNG, Sansera Engineering, Relaxo Footwears, Bata India and Eureka Forbes have featured in HDFC Securities' latest Q1 FY27 review basket. The brokerage maintained its constructive stance on capital goods, infrastructure, pharma, healthcare, insurance and engineering plays while turning cautious on select names due to valuation and profitability concerns. The latest ratings come after these companies reported their June-quarter earnings, with HDFC Securities providing updated target prices and outlook for each stock.
Among the stocks under coverage, Eureka Forbes offers the highest upside potential at around 45%, followed by Max Financial Services and Apollo Hospitals. As per NDTV Profit, the brokerage's preferred picks include companies with strong growth visibility and improving fundamentals across various sectors. The focus on healthcare, insurance and engineering names reflects HDFC Securities' confidence in these segments despite mixed performance across the broader market.
As reported by NDTV Profit, HDFC Securities maintained its Buy rating and raised the target price to ₹4,374 from ₹4,275 for Siemens India. The brokerage highlighted strong order inflows of ₹6,300 crore and an order book of ₹46,700 crore, supported by demand from grid modernisation, data centres, railways and industrial automation. However, commodity inflation, forex headwinds and Middle East disruptions weighed on margins during the quarter. The updated target price reflects the company's robust order book position and growth prospects in key infrastructure segments.
According to NDTV Profit, HDFC Securities retained its 'Buy' rating with a revised target price of ₹10,000, up from ₹9,680 for Apollo Hospitals Enterprise. The brokerage cited strong growth visibility across its hospitals, HealthCo and AHLL businesses, supported by improving occupancy, higher average revenue per patient and ongoing capacity expansion plans. Apollo Hospitals reported 21% revenue growth and 28% Ebitda growth in the June quarter, demonstrating robust operational performance. The revised target price reflects the company's strong fundamentals and growth trajectory in the healthcare sector.
As reported by NDTV Profit, HDFC Securities reiterated its 'BUY' rating and sharply raised its target price to ₹4,140 from ₹3,382 for Sansera Engineering. The brokerage cited strong traction in the Aerospace, Defence and Semiconductor (ADS) segment and improving earnings visibility as key drivers for the upgrade. The revised target price reflects the company's strong positioning in high-growth segments and enhanced earnings prospects in the engineering sector.
Piccadily Agro delivered impressive Q1 FY27 results with net profit rising 15.35% to ₹21.3 crore and revenue increasing 18.12% to ₹270.50 crore, as reported by PTI. The company's branded Alcobev portfolio grew 47.3% year-over-year, with the segment now contributing 43.5% of distillery revenue compared to 37.8% in Q1 FY26. Revenue from the distillery business surged 26.3% to ₹205.65 crore, driven by sustained consumer demand for brands like Indri Single Malt Whisky and Camikara Rum. However, the sugar business revenue declined 1.5% to ₹65.16 crore during the quarter. CFO Natwar Aggarwal expressed optimism about delivering 60-70% growth for the full year, with H2 expected to contribute approximately 60-65% of annual revenue.
According to Business Standard, Bharat Forge reported mixed performance in Q1 FY27 with revenue growth of 19% on consolidated basis and 12% on standalone basis. The company's domestic auto segment grew 3% while overseas auto grew 10%, with industrial business showing healthy growth of 16% each in domestic and overseas markets. However, consolidated operating profit margin fell 190 basis points quarter-on-quarter to 15.3% due to commodity cost pressures and US plant breakdown. The company secured new orders worth ₹1,352 crore in Q1, including ₹681 crore from defence sector, with defence order book now standing at ₹11,200 crore. Despite margin pressures, brokerages remain positive on the outlook given sustained commercial vehicle growth and defence business ramp-up.
